# PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma

> **NCT00512980** · PHASE2 · TERMINATED · sponsor: **University of Cologne**

## Conditions studied

- Hodgkin Lymphoma

## Interventions

- **DRUG:** prednisone
- **DRUG:** vinblastine
- **DRUG:** doxorubicin
- **DRUG:** gemcitabine

## Key facts

- **NCT ID:** NCT00512980
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2013-11
- **Final completion:** —
- **Target enrollment:** — (—)
- **Why stopped:** lower recruitment rates as expected
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00512980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00512980, "PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00512980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*